Sbir PH II topic & prototype development ussocom 17.2 topic 0002
Ended Definitive Contract Awarded Last action
- Contract number
- H9240519C0004
- Awardee
-
Rejuvenate Bio Inc. UEI GEKFSVSTKK55
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Obligated
- $1,975,972
Award facts
- Contract value 100% obligated
- $1,975,972.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- US Special Operations Command Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor Address Change | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $534,705 | |
| Funding Only Action | $441,267 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,000,000 |
Show all 11
About this award
This federal contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for SBIR Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The $1,975,972.00 cost-plus-fixed-fee contract was designated as a total small business set-aside. Rejuvenate Bio Inc. has previously received other SBIR Phase I, II, and II plus prototype development awards from USSOCOM, ranging from approximately $1.4 million to $2.2 million, to conduct research in these areas aimed at enhancing special operations forces capabilities. This contract has a period of performance from November 29, 2018 to August 30, 2021.
Quick answers
Who was awarded contract H9240519C0004?
H9240519C0004 was awarded to Rejuvenate Bio Inc. by Defense Contract Management Agency (Department of Defense) on November 29, 2018.
How much is contract H9240519C0004 worth?
The government has obligated $1,975,972 on H9240519C0004.
Which agency awarded contract H9240519C0004?
Defense Contract Management Agency (Department of Defense) awarded H9240519C0004, with funding from US Special Operations Command (Department of Defense).
Was contract H9240519C0004 competed?
The extent of competition for H9240519C0004 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award